Quick Answer
Collagen Joint Health Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: The present study aimed to evaluate the efficacy and tolerability of native (undenatured) type-II collagen in the joint function of healthy volunteers who experienced joint discomfort as a result of physical activity.
Key Takeaways
- 01The present study aimed to evaluate the efficacy and tolerability of native (undenatured) type-II collagen in the joint function of healthy volunteers who experienced joint discomfort as a result of physical activity. [Möller I (2026)]
- 02In the subgroups of subjects with higher basal joint discomfort during activity (VAS>40 mm) between-group differences were detected on the progression of CTX-II concentration from baseline, which decreased in CN2 and increased in PBO group. [Möller I (2026)]
- 03CONCLUSIONS: This study found that supplementation with CN2, containing native (undenatured) type II collagen supports certain aspects of joint health in people who experience joint discomfort after exercise, including improvements in joint function, discomfort and their impact on quality of life. [Möller I (2026)]
- 04BACKGROUND: In non-osteoarthritic individuals, the appearance of joint discomfort with physical activity is a potential indicator of initial joint degeneration. [Möller I (2026)]
The current Migaku evidence database contains 2 reusable source documents for Collagen Joint Health Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- The present study aimed to evaluate the efficacy and tolerability of native (undenatured) type-II collagen in the joint function of healthy volunteers who experienced joint discomfort as a result of physical activity. [Möller I (2026); evidence level 2]
- In the subgroups of subjects with higher basal joint discomfort during activity (VAS>40 mm) between-group differences were detected on the progression of CTX-II concentration from baseline, which decreased in CN2 and increased in PBO group. [Möller I (2026); evidence level 2]
- CONCLUSIONS: This study found that supplementation with CN2, containing native (undenatured) type II collagen supports certain aspects of joint health in people who experience joint discomfort after exercise, including improvements in joint function, discomfort and their impact on quality of life. [Möller I (2026); evidence level 2]
- BACKGROUND: In non-osteoarthritic individuals, the appearance of joint discomfort with physical activity is a potential indicator of initial joint degeneration. [Möller I (2026); evidence level 2]
- Osteoarthritis (OA) is prevalent in the Indian subcontinent and Southeast Asia, causing pain, reduced mobility, and disability. [Prabhoo R (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Efficacy and tolerability of native (undenatured) type II collagen supplementation for joint health in healthy volunteers: a randomized double-blind placebo-controlled study.
- Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.